NKGen Biotech Inc. (GFOR) NEW YORK STOCK EXCHANGE INC.
$2.32 - (-)
Market Cap: $68.05M
As of 03/22/24 12:00 AM EDT. Market closed.
NKGen Biotech Inc. (GFOR)
NEW YORK STOCK EXCHANGE INC.
$2.32
- (-)
Market Cap: $68.05M
As of 03/22/24 12:00 AM EDT. Market closed.
Add to Portfolio
graf industrial corp is a blank check company. the company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. it intends to focus on industrial companies. it focuses on diversified industrial manufacturing, technology, distribution and service businesses, in the ... read more
COMPANY PROFILE
Sector
Industry
PRICE CHART FOR NKGEN BIOTECH INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$2.32
Days Range
$2.27 - $2.46
52 week range
$6.56 - $12.88
Volume
881
Avg. Volume (30 days)
289,773
Market Cap
$68.05M
Dividend Yield
-
P/E
-
Shares Outstanding
10,373,875
Open
-
Previous Close
$2.32
Days Range
$2.27 - $2.46
52 week range
$6.56 - $12.88
Volume
881
Avg. Volume (30 days)
289,773
Market Cap
$68.05M
Dividend Yield
-
P/E
-
Shares Outstanding
10,373,875
FINANCIAL STATEMENTS FOR NKGEN BIOTECH INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NKGEN BIOTECH INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Song Paul Y. | Chief Executive Officer | Dec 07, 2023 | Buy | $3.29 | 76 | 250 | 171,121 | Dec 07, 2023, 05:23 PM |
| Song Paul Y. | Chief Executive Officer | Dec 06, 2023 | Buy | $3.32 | 75 | 249 | 171,045 | Dec 07, 2023, 05:23 PM |
| Song Paul Y. | Chief Executive Officer | Dec 05, 2023 | Buy | $3.33 | 105 | 350 | 170,969 | Dec 05, 2023, 03:51 PM |
| Song Paul Y. | Chief Executive Officer | Dec 04, 2023 | Buy | $3.07 | 163 | 500 | 170,864 | Dec 05, 2023, 03:51 PM |
| Graf James A | Interim CFO | Dec 04, 2023 | Buy | $3.19 | 450 | 1,436 | 693 | Dec 05, 2023, 03:50 PM |
| Graf James A | Interim CFO | Dec 01, 2023 | Buy | $3.35 | 220 | 737 | 243 | Dec 05, 2023, 03:50 PM |
| Song Paul Y. | Chief Executive Officer | Nov 27, 2023 | Buy | $2.88 | 243 | 699 | 170,701 | Nov 28, 2023, 04:10 PM |
| Graf James A | Interim CFO | Nov 21, 2023 | Buy | $2.91 | 13 | 38 | 23 | Nov 22, 2023, 05:55 PM |
| Graf James A | Interim CFO | Nov 20, 2023 | Buy | $2.94 | 10 | 29 | 10 | Nov 22, 2023, 05:55 PM |
| Song Paul Y. | Chief Executive Officer | Nov 21, 2023 | Buy | $2.80 | 100 | 280 | 170,405 | Nov 22, 2023, 05:53 PM |
| Song Paul Y. | Chief Executive Officer | Nov 22, 2023 | Buy | $2.85 | 53 | 151 | 170,458 | Nov 22, 2023, 05:53 PM |
| Garcia Gus | Co-President | May 26, 2021 | Buy | $9.92 | 900 | 8,928 | 1,500 | May 26, 2021, 09:05 PM |
| Garcia Gus | Co-President | May 25, 2021 | Buy | $9.93 | 600 | 5,958 | 600 | May 26, 2021, 09:05 PM |
| Graf James A | Chief Executive Officer | May 25, 2021 | Buy | $9.90 | 222 | 2,198 | 4,253,800 | May 25, 2021, 07:45 PM |
| Graf James A | Chief Executive Officer | May 24, 2021 | Buy | $9.94 | 28 | 278 | 4,253,578 | May 25, 2021, 07:45 PM |
| Graf James A | Chief Executive Officer | May 21, 2021 | Buy | $9.95 | 1,050 | 10,447 | 4,253,550 | May 25, 2021, 07:45 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Song Paul Y. | Chief Executive Officer | 12/07/2023 | 250 |
| Song Paul Y. | Chief Executive Officer | 12/06/2023 | 249 |
| Song Paul Y. | Chief Executive Officer | 12/05/2023 | 350 |
| Song Paul Y. | Chief Executive Officer | 12/04/2023 | 500 |
| Graf James A | Interim CFO | 12/04/2023 | 1,436 |
| Graf James A | Interim CFO | 12/01/2023 | 737 |
| Song Paul Y. | Chief Executive Officer | 11/27/2023 | 699 |
| Graf James A | Interim CFO | 11/21/2023 | 38 |
| Graf James A | Interim CFO | 11/20/2023 | 29 |
| Song Paul Y. | Chief Executive Officer | 11/21/2023 | 280 |
| Song Paul Y. | Chief Executive Officer | 11/22/2023 | 151 |
| Garcia Gus | Co-President | 05/26/2021 | 8,928 |
| Garcia Gus | Co-President | 05/25/2021 | 5,958 |
| Graf James A | Chief Executive Officer | 05/25/2021 | 2,198 |
| Graf James A | Chief Executive Officer | 05/24/2021 | 278 |
| Graf James A | Chief Executive Officer | 05/21/2021 | 10,447 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR NKGEN BIOTECH INC
STOCK BUYBACKS FOR NKGEN BIOTECH INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
15.14%
1Q
12/31/2022
-0.88%
4Q
06/30/2022
6.61%
6Q
03/31/2022
6.99%
7Q
12/31/2021
2.38%
8Q
09/30/2021
-28.09%
9Q
06/30/2021
44.04%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NKGEN BIOTECH INC
LOADING...